LymphedemaV1, PubMed, Corpus, bibRecord, 002618

Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs.

Identifieur interne : 002618 ( PubMed/Corpus ); précédent : 002617; suivant : 002619

Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs.

Auteurs : Charles D. Mackenzie ; Timothy G. Geary

Source :

Expert review of anti-infective therapy [ 1744-8336 ] ; 2011.

RBID : pubmed:21609260

English descriptors

KwdEn :
- Animals, Anthelmintics (pharmacology), Brugia (drug effects), Brugia (growth & development), Chemistry, Pharmaceutical (methods), Diethylcarbamazine (pharmacology), Drug Therapy, Combination (methods), Elephantiasis, Filarial (drug therapy), Elephantiasis, Filarial (parasitology), Excipients (pharmacology), Filaricides (pharmacology), Humans, Ivermectin (pharmacology), Mebendazole (analogs & derivatives), Mebendazole (pharmacology), Onchocerca volvulus (drug effects), Onchocerca volvulus (growth & development), Onchocerciasis (drug therapy), Onchocerciasis (parasitology), beta-Cyclodextrins (pharmacology).
MESH :
- chemical , analogs & derivatives : Mebendazole.
- chemical , pharmacology : Anthelmintics, Diethylcarbamazine, Excipients, Filaricides, Ivermectin, Mebendazole, beta-Cyclodextrins.
- drug effects : Brugia, Onchocerca volvulus.
- drug therapy : Elephantiasis, Filarial, Onchocerciasis.
- growth & development : Brugia, Onchocerca volvulus.
- methods : Chemistry, Pharmaceutical, Drug Therapy, Combination.
- parasitology : Elephantiasis, Filarial, Onchocerciasis.
- Animals, Humans.

DOI: 10.1586/eri.11.30
PubMed: 21609260

Links to Exploration step

pubmed:21609260

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs.</title>
<author><name sortKey="Mackenzie, Charles D" sort="Mackenzie, Charles D" uniqKey="Mackenzie C" first="Charles D" last="Mackenzie">Charles D. Mackenzie</name>
</author>
<author><name sortKey="Geary, Timothy G" sort="Geary, Timothy G" uniqKey="Geary T" first="Timothy G" last="Geary">Timothy G. Geary</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2011">2011</date>
<idno type="RBID">pubmed:21609260</idno>
<idno type="pmid">21609260</idno>
<idno type="doi">10.1586/eri.11.30</idno>
<idno type="wicri:Area/PubMed/Corpus">002618</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002618</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs.</title>
<author><name sortKey="Mackenzie, Charles D" sort="Mackenzie, Charles D" uniqKey="Mackenzie C" first="Charles D" last="Mackenzie">Charles D. Mackenzie</name>
</author>
<author><name sortKey="Geary, Timothy G" sort="Geary, Timothy G" uniqKey="Geary T" first="Timothy G" last="Geary">Timothy G. Geary</name>
</author>
</analytic>
<series><title level="j">Expert review of anti-infective therapy</title>
<idno type="eISSN">1744-8336</idno>
<imprint><date when="2011" type="published">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Anthelmintics (pharmacology)</term>
<term>Brugia (drug effects)</term>
<term>Brugia (growth & development)</term>
<term>Chemistry, Pharmaceutical (methods)</term>
<term>Diethylcarbamazine (pharmacology)</term>
<term>Drug Therapy, Combination (methods)</term>
<term>Elephantiasis, Filarial (drug therapy)</term>
<term>Elephantiasis, Filarial (parasitology)</term>
<term>Excipients (pharmacology)</term>
<term>Filaricides (pharmacology)</term>
<term>Humans</term>
<term>Ivermectin (pharmacology)</term>
<term>Mebendazole (analogs & derivatives)</term>
<term>Mebendazole (pharmacology)</term>
<term>Onchocerca volvulus (drug effects)</term>
<term>Onchocerca volvulus (growth & development)</term>
<term>Onchocerciasis (drug therapy)</term>
<term>Onchocerciasis (parasitology)</term>
<term>beta-Cyclodextrins (pharmacology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Mebendazole</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Anthelmintics</term>
<term>Diethylcarbamazine</term>
<term>Excipients</term>
<term>Filaricides</term>
<term>Ivermectin</term>
<term>Mebendazole</term>
<term>beta-Cyclodextrins</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Brugia</term>
<term>Onchocerca volvulus</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term>
<term>Onchocerciasis</term>
</keywords>
<keywords scheme="MESH" qualifier="growth & development" xml:lang="en"><term>Brugia</term>
<term>Onchocerca volvulus</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Chemistry, Pharmaceutical</term>
<term>Drug Therapy, Combination</term>
</keywords>
<keywords scheme="MESH" qualifier="parasitology" xml:lang="en"><term>Elephantiasis, Filarial</term>
<term>Onchocerciasis</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Humans</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21609260</PMID>
<DateCreated><Year>2011</Year>
<Month>05</Month>
<Day>25</Day>
</DateCreated>
<DateCompleted><Year>2011</Year>
<Month>09</Month>
<Day>21</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1744-8336</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>9</Volume>
<Issue>5</Issue>
<PubDate><Year>2011</Year>
<Month>May</Month>
</PubDate>
</JournalIssue>
<Title>Expert review of anti-infective therapy</Title>
<ISOAbbreviation>Expert Rev Anti Infect Ther</ISOAbbreviation>
</Journal>
<ArticleTitle>Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs.</ArticleTitle>
<Pagination><MedlinePgn>497-501</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1586/eri.11.30</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mackenzie</LastName>
<ForeName>Charles D</ForeName>
<Initials>CD</Initials>
</Author>
<Author ValidYN="Y"><LastName>Geary</LastName>
<ForeName>Timothy G</ForeName>
<Initials>TG</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Expert Rev Anti Infect Ther</MedlineTA>
<NlmUniqueID>101181284</NlmUniqueID>
<ISSNLinking>1478-7210</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000871">Anthelmintics</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D005079">Excipients</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D005369">Filaricides</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D047392">beta-Cyclodextrins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>70288-86-7</RegistryNumber>
<NameOfSubstance UI="D007559">Ivermectin</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>81G6I5V05I</RegistryNumber>
<NameOfSubstance UI="D008463">Mebendazole</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>94035-02-6</RegistryNumber>
<NameOfSubstance UI="C053839">2-hydroxypropyl-beta-cyclodextrin</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>R8M46911LR</RegistryNumber>
<NameOfSubstance UI="C018945">flubendazole</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>V867Q8X3ZD</RegistryNumber>
<NameOfSubstance UI="D004049">Diethylcarbamazine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000871" MajorTopicYN="N">Anthelmintics</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002009" MajorTopicYN="N">Brugia</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
<QualifierName UI="Q000254" MajorTopicYN="N">growth & development</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002626" MajorTopicYN="N">Chemistry, Pharmaceutical</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004049" MajorTopicYN="N">Diethylcarbamazine</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000469" MajorTopicYN="N">parasitology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005079" MajorTopicYN="N">Excipients</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005369" MajorTopicYN="N">Filaricides</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007559" MajorTopicYN="N">Ivermectin</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008463" MajorTopicYN="N">Mebendazole</DescriptorName>
<QualifierName UI="Q000031" MajorTopicYN="Y">analogs & derivatives</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017181" MajorTopicYN="N">Onchocerca volvulus</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
<QualifierName UI="Q000254" MajorTopicYN="N">growth & development</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009855" MajorTopicYN="N">Onchocerciasis</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000469" MajorTopicYN="N">parasitology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D047392" MajorTopicYN="N">beta-Cyclodextrins</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year>
<Month>5</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2011</Year>
<Month>5</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2011</Year>
<Month>9</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">21609260</ArticleId>
<ArticleId IdType="doi">10.1586/eri.11.30</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002618 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002618 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:21609260
   |texte=   Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:21609260" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs.

Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs.

Source :

English descriptors

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki